July 03, 2022
1 min watch
Save
VIDEO: Aerie provides update on dry eye candidate
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
NEWPORT BEACH, Calif. — In this Healio Video Perspective, Michelle Senchyna, PhD, vice president of clinical development and medical affairs at Aerie, discusses progress in clinical trials for its dry eye candidate AR-15512.
Published by:
Sources/Disclosures
Collapse
Source:
Healio Interviews
Disclosures:
Senchyna reports being vice president of clinical development and medical affairs for Aerie Pharmaceuticals.
Read more about
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.